Avenue Therapeutics Stock (NASDAQ: ATXI) stock price, news, charts, stock research, profile.
Open | $3.43 |
Close | $3.41 |
Volume / Avg. | 15.31K / 61.89K |
Day Range | 3.26 - 3.46 |
52 Wk Range | 3.25 - 93.75 |
Market Cap | $3.46M |
P/E Ratio | 0.27 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 4.51% |
Days to Cover | 1.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avenue Therapeutics (NASDAQ:ATXI) through any online brokerage.
Other companies in Avenue Therapeutics’s space includes: Cingulate (NASDAQ:CING), Biofrontera (NASDAQ:BFRI), NovaBay Pharmaceuticals (AMEX:NBY), cbdMD (AMEX:YCBD) and Titan Pharma (NASDAQ:TTNP).
There is no analysis for Avenue Therapeutics.
Avenue Therapeutics has a consensus price target of $16.38.
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $3.68 last updated July 2, 2024 at 7:42 AM EDT.
There are no upcoming dividends for Avenue Therapeutics.
Avenue Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Avenue Therapeutics.
Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.